US Stock MarketDetailed Quotes
NAVB Navidea Biopharmaceuticals
- 0.038
- +0.003+9.29%
15min DelayClose May 3 16:00 ET
3.83MMarket Cap-478P/E (TTM)
0.040High0.035Low3.37KVolume0.035Open0.035Pre Close129.79Turnover0.01%Turnover RatioLossP/E (Static)100.08MShares0.19452wk High-1.16P/B2.59MFloat Cap0.02152wk Low--Dividend TTM67.83MShs Float365.000Historical High--Div YieldTTM14.14%Amplitude0.021Historical Low0.038Avg Price1Lot Size
Navidea Biopharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | -67.89%14.65K | -35.79%610 | -17.55%7.52K | -50.10%6.52K | 0 | -61.58%45.62K | -98.92%950 |
| Operating revenue | --0 | --0 | --0 | -67.89%14.65K | -35.79%610 | -17.55%7.52K | -50.10%6.52K | --0 | -61.58%45.62K | -98.92%950 |
| Cost of revenue | 0 | 0 | 184.95K | 50.04K | 134.44K | 473 | 0 | 0 | ||
| Gross profit | 0 | 0 | -473.35%-170.3K | -5,302.74%-49.43K | -1,492.30%-126.92K | -53.72%6.05K | -61.24%45.62K | -98.92%950 | ||
| Operating expense | -55.82%2.13M | -17.11%2.43M | -18.69%2.42M | 14.66%13.88M | -13.50%3.15M | 98.44%4.82M | 9.17%2.93M | -11.13%2.98M | 11.79%12.11M | 26.03%3.64M |
| Selling and administrative expenses | -64.21%1.3M | 5.24%1.32M | -36.19%1.15M | 6.87%7.96M | -45.68%1.26M | 147.55%3.64M | -12.35%1.26M | -18.86%1.81M | 11.28%7.45M | 32.52%2.32M |
| Research and development costs | -30.07%829.61K | -35.83%1.11M | 8.40%1.27M | 16.10%5.97M | 37.73%1.89M | 13.12%1.19M | 15.08%1.72M | -4.38%1.17M | 4.29%5.14M | 7.96%1.37M |
| Other operating expenses | ---- | ---- | ---- | 89.50%-51.01K | --0 | ---- | 79.43%-51.01K | ---- | 38.98%-485.9K | 62.42%-49.4K |
| Operating profit | 56.95%-2.13M | 16.93%-2.43M | 18.69%-2.42M | -16.50%-14.05M | 12.12%-3.2M | -104.43%-4.95M | -9.48%-2.92M | 10.53%-2.98M | -12.60%-12.06M | -29.95%-3.64M |
| Net non-operating interest income expense | 86.61%-102.51K | 835.04%614.38K | -7,087.19%-263.2K | -17,166.50%-1.1M | -12,573.89%-245.62K | -27,101.71%-765.46K | -6,702.21%-83.58K | -27.37%-3.66K | -156.07%-6.36K | -31.12%-1.94K |
| Non-operating interest expense | ---- | ---- | 7,087.19%263.2K | 17,166.50%1.1M | ---- | ---- | ---- | 27.37%3.66K | --6.36K | ---- |
| Total other finance cost | -86.61%102.51K | -835.04%-614.38K | ---- | ---- | ---- | 27,101.71%765.46K | 6,702.21%83.58K | ---- | ---- | ---- |
| Other net income (expense) | -355.13%-21.49K | 6,146.42%420.13K | 28,228.26%1.21M | -107.94%-27.94K | -250.17%-38.43K | 200.79%8.42K | 218.29%6.73K | -101.18%-4.3K | 1,710.16%351.89K | 47.93%-10.97K |
| Special income (charges) | --0 | --564.94K | ---- | --0 | --0 | --0 | --0 | ---- | --366K | --0 |
| -Less:Other special charges | ---- | --185.06K | ---- | ---- | ---- | ---- | ---- | ---- | ---366K | --0 |
| -Gain on sale of property,plant,equipment | --0 | --750K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Other non- operating income (expenses) | -355.13%-21.49K | -2,252.99%-144.81K | 28,228.26%1.21M | -97.94%-27.94K | -250.17%-38.43K | 200.79%8.42K | 218.29%6.73K | -1,585.88%-4.3K | 35.41%-14.12K | 47.93%-10.97K |
| Income before tax | 60.49%-2.26M | 53.55%-1.39M | 50.58%-1.48M | -29.55%-15.18M | 4.65%-3.48M | -135.69%-5.71M | -12.17%-3M | -0.69%-2.99M | -9.26%-11.71M | -29.37%-3.65M |
| Income tax | 0 | 16.04K | 0 | |||||||
| Net income | 60.49%-2.26M | 301.10%6.03M | 50.58%-1.48M | -29.38%-15.18M | 4.64%-3.48M | -134.13%-5.71M | -12.17%-3M | -0.69%-2.99M | -9.41%-11.73M | -29.37%-3.65M |
| Net income continuous Operations | 60.49%-2.26M | 53.55%-1.39M | 50.58%-1.48M | -29.38%-15.18M | 4.64%-3.48M | -134.13%-5.71M | -12.17%-3M | -0.69%-2.99M | -9.41%-11.73M | -29.37%-3.65M |
| Net income discontinuous operations | --0 | --7.43M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Minority interest income | -1 | 0 | 66.67%-1 | 25.00%-3 | 1 | 0 | 0.00%-1 | -50.00%-3 | -4 | 0 |
| Net income attributable to the parent company | 60.49%-2.26M | 301.10%6.03M | 50.58%-1.48M | -29.38%-15.18M | 4.64%-3.48M | -134.14%-5.71M | -12.17%-3M | -0.69%-2.99M | -9.41%-11.73M | -29.37%-3.65M |
| Preferred stock dividends | 206.98K | 2.04M | 0 | 2.04M | ||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 70.88%-2.26M | 294.20%5.82M | 50.58%-1.48M | -46.75%-17.22M | 4.64%-3.48M | -217.73%-7.75M | -12.17%-3M | -0.69%-2.99M | -3.03%-11.73M | -21.59%-3.65M |
| Basic earnings per share | 92.00%-0.02 | 220.00%0.12 | 50.00%-0.05 | -40.00%-0.56 | 8.33%-0.11 | -212.50%-0.25 | -11.11%-0.1 | 9.09%-0.1 | 16.67%-0.4 | -9.09%-0.12 |
| Diluted earnings per share | 92.00%-0.02 | 220.00%0.12 | 50.00%-0.05 | -40.00%-0.56 | 8.33%-0.11 | -212.50%-0.25 | -11.11%-0.1 | 9.09%-0.1 | 16.67%-0.4 | -9.09%-0.12 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg